Endogenous risk factors for deep-vein thrombosis in patients with acute spinal cord injuries

Spinal Cord

Volumn 45, Issue 9, 2007, Pages 627-631

  Aito, S ^a   Abbate, R ^a   Marcucci, R ^a   Cominelli, E ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Acute spinal cord lesion; Deep vein thrombosis; Hyperhomocisteinemia; PAI 1; Risk factor for DVT; Thrombosis prophylaxis

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5 LEIDEN; HOMOCYSTEINE; LIPOPROTEIN A; PROTEIN C; PROTEIN S;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DNA POLYMORPHISM; FEMALE; FISHER EXACT TEST; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANK SUM TEST; RISK FACTOR; SPINAL CORD INJURY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SPINAL CORD INJURIES; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 34548478103     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sj.sc.3102018     Document Type: Article

References (25)

1. Kulkarni JR, Burt AA, Tromans AT, Constable PD. Prophylactic low dose heparin anticoagulant therapy in patients with spinal cord injuries: a retrospective study. Paraplegia 1992; 30: 169-172.
2. Waring WP, Karunas RS. Acute spinal cord injuries and the incidence of clinically occurring thromboembolic disease. Paraplegia 1991; 29: 8-16.
3. Merli GJ et al. Aetiology, incidence, and prevention of deepvein thrombosis in acute spinal cord injury. Arch Phys Med Rehabil 1993; 74: 1199-1205.
4. Aito S, Pieri A, D'Andrea M, Marcelli F, Cominelli E. Primary prevention of deep venous thrombosis and pulmonary embolism in acute spinal cord injured patients. Spinal Cord 2002; 40: 300-303.
5. Yelnik A et al. Systematic lower limb phlebography in acute spinal cord injury in 147 patients. Paraplegia 1991; 29: 253-260.
6. Powell M, Kirschblum S, O'Connor KC. Duplex ultrasound screening for deepvein thrombosis in spinal cord injured patients at rehabilitation admission. Arch Phys Med Rehabil 1999; 80: 1044-1046.
7. Gunduz S et al. Deepvein thrombosis in spinal cord injured patients. Paraplegia 1993; 31: 606-610.
8. Rossi E, Green D, Rosen J. Sequential changes in factor VIII and platelets preceding deep vein thrombosis in patients with spinal cord injury. Br J Haematol 1980; 45: 143-151.
9. Lopez JA, Kearon C, Lee AY. Deep venous thrombosis. Hematology (Am Soc Hematol Educ Program) 2004; 439-456 Review.
10. De Stefano V, Finazzi G. Mannucci, inherited thrombophilia: pathogenesis clinical syndromes management. Blood 1996; 87: 3531-3544.
11. Huber K et al. Plasminogen activator inhibitor type-1 in cardiovascular disease, status report 2001. Thromb Res 2001; 103(Suppl 1): S7-S19.
12. De Stefano V, Rossi E, Paciaroni K, Leone G. Screening for inherited thrombophilia: indications and therapeutic implications. Haematologica 2002; 87: 1095-1108.
13. Price DT, Ridker PM. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Ann Intern Med 1997; 127: 895-903.
14. Loscalzo J et al. Lipoprotein(a), fibrin binding, and plasminogen activation. Arteriosclerosis 1990; 10: 240-245.
15. Stein JH, Rosenson RS. Lipoprotein Lp(a) excess and coronary heart disease. Arch Intern Med 1997; 157: 1170-1176.
16. Cressman MD et al. Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 1992; 86: 475-482.
17. Wanner C et al. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome. Ann Intern Med 1993; 119: 263-269.
18. Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999; 19: 217-246.
19. Marino RJ et al. ASIA neurological standards committee 2002. International standards for neurological classification of spinal cord injury. J Spinal Cord Med 2003; 26: S50-S56.
20. Abbate R et al. The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD). Thromb Haemost 1998; 79: 727-730.
21. Cattaneo M, Lombardi R, Lecchi A, Bucciarelli P, Mannucci PM. Low plasma levels of vitamin B(6) are independently associated with a heightened risk of deep-vein thrombosis. Circulation 2001; 104: 2442-2446.
22. Robinson K et al. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation 1998; 97: 437-443.
23. Kohler HP, Grant PJ. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 2000; 342: 1792-1801.
24. Crowther MA et al. Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study. Thromb Haemost 2001; 85: 390-394.
25. Kaba NK et al., THROMBO Investigators. Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction. J Thromb Haemost 2004; 2: 718-725.